Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases (CITRUS)
Randomized, Parallel and Double Blind Placebo-controlled Study for the Evaluation of Both Acute and Chronic Role of Hesperidin Consumption in 100% Orange Juice
Sponsor: Florida Department of Citrus
Listed as NCT02479568, this PHASE3 trial focuses on Cardiovascular Risk Factors and remains completed. Sponsored by Florida Department of Citrus, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Jan 2021 — Mar 2022 [monthly]
Unknown Status PHASE3
-
Jul 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Florida Department of Citrus
- Hospital Universitari Sant Joan de Reus
- Technological Centre of Nutrition and Health
- Technological Centre of Nutrition and Health, Spain
- University Rovira i Virgili
For direct contact, visit the study record on ClinicalTrials.gov .